Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival Article Swipe
Related Concepts
Biomaterial
Immunotherapy
Immune system
Cancer research
Cancer immunotherapy
Transplantation
Medicine
Immunology
Biomedical engineering
Internal medicine
María M. Coronel
,
Karen E. Martin
,
Michael D. Hunckler
,
Graham F. Barber
,
Eric B. O’Neill
,
Juan D. Medina
,
Enrico Opri
,
Claire A. McClain
,
Lalit Batra
,
Jessica D. Weaver
,
Hong Seo Lim
,
Peng Qiu
,
Edward A. Botchwey
,
Esma S. Yolcu
,
Haval Shirwan
,
Andrés J. Garcı́a
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1126/sciadv.aba5573
· OA: W3081709993
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1126/sciadv.aba5573
· OA: W3081709993
Local biomaterial-mediated delivery of PD-L1 induces alloislet graft survival and function in a murine model of type 1 diabetes.
Related Topics
Finding more related topics…